The OHSU Blood-Brain Barrier and Neuro-Oncology Program conducts innovative patient-oriented research in all aspects of imaging and therapy of brain tumors. New discoveries from the BBB program are creating hope for detection and treatment of these horrible cancers. Our goal is to translate cutting-edge research from the benchtop to the clinic to improve neuro-oncological outcomes for patients.
Clinical research in the BBB Program is headed by Nancy D. Doolittle, R.N., Ph.D., Associate Professor in the Department of Neurology.
Basic Science and preclinical research in the BBB Program is headed by Leslie L. Muldoon, Ph.D., Associate Professor in the Department of Neurology
Clinical studies open to subject enrollment
Please see clinical trials for information and eligibility requirements for our open clinical studies.